Mar Bellido

1.7k total citations
47 papers, 997 citations indexed

About

Mar Bellido is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Mar Bellido has authored 47 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 14 papers in Genetics and 12 papers in Oncology. Recurrent topics in Mar Bellido's work include Chronic Lymphocytic Leukemia Research (13 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (10 papers). Mar Bellido is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (10 papers). Mar Bellido collaborates with scholars based in Spain, Netherlands and United States. Mar Bellido's co-authors include Jorge Sierra, Josep Nomdedéu, Salut Brunet, Mercedes Herrera, Luz Muñoz, Maria J. Carnicer, Olga López, Carlos Fernández‐Delgado, J.A. Hernando and Anna Sureda and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Transplantation.

In The Last Decade

Mar Bellido

46 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mar Bellido Spain	16	275	267	213	197	178	47	997
Владимир Трифонов United States	9	395 1.4×	75 0.3×	421 2.0×	705 3.6×	350 2.0×	31	1.7k
Ulrich Laß Germany	9	508 1.8×	61 0.2×	206 1.0×	74 0.4×	51 0.3×	11	1.2k
Alberto Gómez Colombia	15	134 0.5×	87 0.3×	130 0.6×	17 0.1×	14 0.1×	109	805
Tsieh Sun United States	22	330 1.2×	165 0.6×	310 1.5×	500 2.5×	260 1.5×	103	1.5k
Lee Ann Baxter‐Lowe United States	28	461 1.7×	1.9k 7.2×	1.7k 7.8×	66 0.3×	341 1.9×	90	3.2k
David J. Schmidt United States	11	87 0.3×	32 0.1×	613 2.9×	27 0.1×	32 0.2×	23	1.2k
Markus Kapp Germany	20	315 1.1×	251 0.9×	269 1.3×	54 0.3×	44 0.2×	51	1.0k
Caroline Reuter United Kingdom	18	96 0.3×	176 0.7×	94 0.4×	39 0.2×	47 0.3×	43	855
Anna Sherwood United States	16	585 2.1×	175 0.7×	981 4.6×	163 0.8×	76 0.4×	23	1.6k
Gunhild Sommer Germany	20	139 0.5×	160 0.6×	213 1.0×	71 0.4×	73 0.4×	33	2.1k

Countries citing papers authored by Mar Bellido

Since Specialization

Citations

This map shows the geographic impact of Mar Bellido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Bellido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Bellido more than expected).

Fields of papers citing papers by Mar Bellido

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mar Bellido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Bellido. The network helps show where Mar Bellido may publish in the future.

Co-authorship network of co-authors of Mar Bellido

This figure shows the co-authorship network connecting the top 25 collaborators of Mar Bellido. A scholar is included among the top collaborators of Mar Bellido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mar Bellido. Mar Bellido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kater, Arnon P., Ann Janssens, Herbert Eradat, et al.. (2024). SINGLE-AGENT EPCORITAMAB LEADS TO DEEP RESPONSES IN PATIENTS (PTS) WITH RICHTER’S TRANSFORMATION (RT): PRIMARY RESULTS FROM THE EPCORE CLL-1 TRIAL. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations

Kater, Arnon P., Ann Janssens, Herbert Eradat, et al.. (2024). Epcoritamab Induces Deep Responses in Patients With Richter Transformation (RT): Primary Results From the EPCORE CLL-1 Trial. Clinical Lymphoma Myeloma & Leukemia. 24. S181–S181. 2 indexed citations

Herling, Marco, Claire Dearden, Francesco Zaja, et al.. (2024). Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study. Blood Advances. 8(4). 842–845. 2 indexed citations

Norden, Yvette van, Jurjen Versluis, Anita W. Rijneveld, et al.. (2024). Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi‐state modeling. Cancer Medicine. 13(9). e6756–e6756. 2 indexed citations

Kater, Arnon P., Ann Janssens, Herbert Eradat, et al.. (2024). CLL-280 Epcoritamab Induces Deep Responses in Patients With Richter Transformation (RT): Primary Results From the EPCORE CLL-1 Trial. Clinical Lymphoma Myeloma & Leukemia. 24. S350–S351. 3 indexed citations

Morsink, Linde M., Goda Choi, Marco R. de Groot, et al.. (2024). Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression. Transplantation and Cellular Therapy. 30(8). 794–807. 4 indexed citations

Dinmohamed, Avinash G., Jurjen Versluis, Bronno van der Holt, et al.. (2023). Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative Conditioning. Transplantation. 107(12). 2561–2567.

Sluis, Joyce van, Mar Bellido, Andor W.J.M. Glaudemans, & Riemer H. J. A. Slart. (2022). Long Axial Field-of-View PET for Ultra-Low-Dose Imaging of Non-Hodgkin Lymphoma during Pregnancy. Diagnostics. 13(1). 28–28. 12 indexed citations

Kater, Arnon P., Jose Sandoval‐Sus, Mar Bellido, et al.. (2022). Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1). Blood. 140(Supplement 1). 850–851. 25 indexed citations

10.

León, Leticia G., Christiaan J. Stavast, Mar Bellido, et al.. (2021). miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia. Leukemia. 36(4). 983–993. 14 indexed citations

11.

Staber, Philipp B., Marco Herling, Mar Bellido, et al.. (2019). Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood. 134(14). 1132–1143. 67 indexed citations

12.

Maggen, Charlotte, Daan Dierickx, Pieternella J. Lugtenburg, et al.. (2019). Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study. The Lancet Haematology. 6(11). e551–e561. 43 indexed citations

13.

Boome, Liane te, Inger S. Nijhof, Suzanne van Dorp, et al.. (2018). Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib. Bone Marrow Transplantation. 53(10). 1255–1262. 14 indexed citations

14.

Morales, Isabel, Lorena López‐Cerero, José Molina, et al.. (2017). Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes. International Journal of Antimicrobial Agents. 49(4). 498–502. 14 indexed citations

15.

López‐Cerero, Lorena, M.D. Navarro, Mar Bellido, et al.. (2013). Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications. Journal of Antimicrobial Chemotherapy. 69(3). 809–814. 57 indexed citations

16.

Pérez, Moisés, Gonzalo Sánchez‐Duffhues, Nieves Márquez, et al.. (2010). Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency. Current HIV Research. 8(6). 418–429. 98 indexed citations

17.

Bellido, Mar, J Ubeda, O. López, et al.. (2001). Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells. European Journal Of Haematology. 66(2). 100–106. 10 indexed citations

18.

Muñoz, Luz, et al.. (2000). CD66 expression in acute leukaemia. Annals of Hematology. 79(6). 299–303. 15 indexed citations

19.

Martino, Rodrigo, Maricel Subirá, Mar Bellido, et al.. (1999). Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. Bone Marrow Transplantation. 24(3). 283–287. 44 indexed citations

20.

Estivill, Camino, et al.. (1998). cCD79a expression in a case of plasma cell leukemia. Leukemia Research. 22(7). 649–653. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact